Hemolytic disease of the newborn has not vanished from Finland--routine protection of RhD negative mothers during pregnancy is justifiable

Prophylaxis of RhD negative mothers with anti-D immunoglobulin after childbirth is the most important procedure reducing the immunization of the mother and the risk of severe hemolytic disease of the newborn. In spite of this, anti-D antibodies having relevance to pregnancy are later detected in 1.8% of RhD negative mothers. Half of these cases could be prevented by routine anti-D prophylaxis given to the mothers during weeks 28 to 34 of pregnancy. Convincing evidence of the effectiveness of this measure has accumulated in the last few years, and application of the treatment is justified also in Finland.

Medienart:

Artikel

Erscheinungsjahr:

2012

Erschienen:

2012

Enthalten in:

Zur Gesamtaufnahme - volume:128

Enthalten in:

Duodecim; laaketieteellinen aikakauskirja - 128(2012), 2 vom: 25., Seite 151-7

Sprache:

Finnisch

Weiterer Titel:

Vastasyntyneen hemolyyttinen tauti ei ole hävinnyt Suomesta

Beteiligte Personen:

Sainio, Susanna [VerfasserIn]
Kuosmanen, Malla [VerfasserIn]

Themen:

English Abstract
Immunologic Factors
Isoantibodies
Journal Article
Rho(D) Immune Globulin

Anmerkungen:

Date Completed 05.04.2012

Date Revised 29.02.2012

published: Print

Citation Status MEDLINE

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM21578328X